|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | A61K 39/00 | (2006.01) |
| A61K 39/395 | (2006.01) | ||
| G01N 33/48 | (2006.01) | ||
| A61P 11/06 | (2006.01) |
| (11) | Number of the document | 3520811 |
| (13) | Kind of document | T |
| (96) | European patent application number | 19158446.5 |
| Date of filing the European patent application | 2014-08-07 | |
| (97) | Date of publication of the European application | 2019-08-07 |
| (45) | Date of publication and mention of the grant of the patent | 2020-12-30 |
| (46) | Date of publication of the claims translation | 2021-03-25 |
| (30) | Number | Date | Country code |
| 201361864948 P | 2013-08-12 | US |
| (72) |
WARD, Christine, US
ROSKOS, Lorin, US
WANG, Bing, US
RAIBLE, Donald, US
|
| (73) |
Astrazeneca AB,
151 85 Södertälje,
SE
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Būdai, skirti atsmatikų priverstinio iškvėpimo tūrio padidinimui naudojant benralizumabą |
| METHODS FOR INCREASING FORCED EXPIRATORY VOLUME IN ASTHMATICS USING BENRALIZUMAB |
| Payment date | Validity (years) | Amount | |
| 2025-07-23 | 12 | 289.00 EUR |
| 2026-08-07 |